Replies to post #11798 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Are you saying that GTCB management would not accept a takeover offer that gets shareholders $0.80 a share if the current share price is $0.40 a share?<

I was not saying that… but since you asked, my answer is that $0.80 would be rejected out of hand. (The decision would not be one for GTC’s management to make but rather for the BoD.)